Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters

Language
Document Type
Year range
2.
17th European Conference on Technology Enhanced Learning, EC-TEL 2022 ; 13450 LNCS:59-73, 2022.
Article in English | Scopus | ID: covidwho-2048153

ABSTRACT

The COVID-19 crisis emphasizes the importance of Self-Regulated Learning (SRL), one of today’s most valuable skills, with which learners set their learning goals, monitor and control their cognition, motivation, and behavior, and reflect upon them. In the current experimental study, an intervention program based on short online interactive videos was developed to promote SRL skills. This paper presents the impact of the intervention on students’ use of SRL skills and grades. It also explores four key pedagogical processes (teacher-student relationships, collaboration, autonomy, and feedback) as mediators for SRL strategies use and grades. The experimental and control groups were randomly assigned (N = 290 students, 18 classes, grades 7–12). Each teacher taught the same subject in two classes for a month, an amount of time that allows intervention to take effect. One of the classes participated in the video-based intervention program (experimental group), whereas the other performed all activities but did not have access to the videos (control group). Data was collected through an SRL and pedagogies usage questionnaire, SRL video prompts, and knowledge tests and was analyzed using the quantitative method. In addition to the theoretical contribution, a practical tool has been developed for educators who wish to employ online SRL training. © 2022, The Author(s), under exclusive license to Springer Nature Switzerland AG.

5.
Hepatology ; 74(SUPPL 1):336A-337A, 2021.
Article in English | EMBASE | ID: covidwho-1508703

ABSTRACT

Background: BNT162b2 mRNA vaccine has been shown to be safe and effective in healthy subjects. The safety and efficacy of this vaccine in liver transplant (LT) recipients is still a subject of evaluation. The objective of this study was to assess the safety and efficacy of BNT162b2 mRNA vaccine among LT recipients. Methods: Immune response of two dose of BNT162b2 mRNA vaccine in 76 LT recipients was compared to 174 age-matched immunocompetent subjects with no exposure to SARS-CoV-2 infection. Postvaccination IgG antibodies against the RBD of SARS-CoV-2 IgG S-protein serology and neutralizing antibodies (NA) to the BNT162b2 mRNA vaccine were determined at least 14 days after the second dose of vaccine. AB titer ≥1.1 was considered protective. Side effects were monitored during study period. Results: Following the administration of the BNT162b2 mRNA two dose vaccines, LT recipients (median age 64 (range 22-83 years), 56.6% males) showed reduced immune response as compared with immunocompetent controls (72% vs. 94.2%, p<0.0001). The geometric mean of titer IgG antibody of SARS-CoV-2 and NA was significantly lower in LT recipients who received combine immunosuppression (combination of CNI and prednisone, and/or MMF and/or everolimus) vs CNI monotherapy 1.1±3.1 vs. 3.5±2.1, p<0.0001, 59.0±3.2 vs. 256.0±4.7, p=0.002. In multivariate analysis, the antibody response was reduced in LT recipients who received combined immunosuppression and in those with impaired renal function. Overall most self-reported side effects that were detected in 39 (51%) LT recipients were mild. The immune response did not correlate with more severe side effects. The side effects occurred more often in women than in men. Conclusion: Compared with immunocompetent subjects, liver transplant recipients had reduced immune response. Factors affecting serological antibodies response include renal function and type of immunosuppression used. Side effects were mild in most cases and more often in women. The durability of immune response to BNT162b2 mRNA vaccine among LT recipients needs further investigation.

SELECTION OF CITATIONS
SEARCH DETAIL